The objective of this study is to evaluate the dose-response of three different dose levels of STA-2 (900 mg daily, 1800 mg daily and 2700 mg daily for 42 days) versus placebo in patients with chronic stable angina.~Treatment Group A:~150 mg STA-2, 2 capsules t.i.d., after meal (900 mg STA-2 total dose per day)~Treatment Group B:~300 mg STA-2, 2 capsules t.i.d., after meal (1800 mg STA-2 total dose per day)~Treatment Group C:~450 mg STA-2, 2 capsules t.i.d., after meal (2700 mg STA-2 total dose per day)~Placebo Group:~Placebo capsule, 2 capsules t.i.d., after meal
The objective of this study is to evaluate the dose-response of three different dose levels of STA-2 (900 mg daily, 1800 mg daily and 2700 mg daily for 42 days) versus placebo in patients with chronic stable angina.